Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer, April 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 323 articles:
HTML format


 

Single Articles

  1. SRINATH A, Pavlova M, Chandar S, Vasudeva Rao S, et al
    Knowledge, attitudes and practices of women regarding breast and cervical cancer screening: a qualitative study in India.
    Glob Public Health. 2025;20:2467785.
    PubMed    
    Abstract available

  2. XU D, Zhao X, Ye D, Huo C, et al
    A gene-based predictive model for lymph node metastasis in cervical cancer: superior performance over imaging techniques.
    J Transl Med. 2025;23:397.
    PubMed    
    Abstract available

  3. NGUYEN TB, Vu KD, Cu LTN, Ngoc MHN, et al
    Socioeconomic inequalities in cervical cancer screening practices in Vietnam: a decomposition analysis.
    BMC Public Health. 2025;25:1253.
    PubMed    
    Abstract available

  4. MAJIMA T, Matsukawa Y, Funahashi Y, Kajikawa K, et al
    Urodynamic assessment and proteomic analysis of lower urinary tract dysfunction following nerve-sparing radical hysterectomy.
    Sci Rep. 2025;15:11474.
    PubMed    
    Abstract available

  5. GUPTA A, Dagar G, Das SK, Chauhan R, et al
    Prognostic value of circulating HPV cell-free DNA in cervical cancer using liquid biopsy.
    Sci Rep. 2025;15:11480.
    PubMed    
    Abstract available

  6. OSMANI V, Rossiter M, Horner L, Nkurunziza T, et al
    Worldwide burden of cervical human papillomavirus (HPV) in women over 50 years with abnormal cytology: a systematic review and meta-analysis.
    BMJ Glob Health. 2025;10:e017309.
    PubMed    
    Abstract available

  7. LIU H, Xu R, Chen J, Wang S, et al
    Viral integration and fusion transcript characteristics of possibly high-risk HPV in cervical cancer.
    Infect Genet Evol. 2025 Apr 1:105746. doi: 10.1016/j.meegid.2025.105746.
    PubMed    
    Abstract available

  8. WANG R, Zhang F, Li J, Yang D, et al
    GATA2 promotes cervical cancer progression under the transcriptional activation of TRIP4.
    Cell Signal. 2025 Apr 1:111778. doi: 10.1016/j.cellsig.2025.111778.
    PubMed    
    Abstract available

  9. CHNG EAC, Smith HE
    Barriers to cervical cancer screening and the potential role of HPV selfsampling in Singapore: A cross-sectional study.
    Ann Acad Med Singap. 2025;54:192-194.
    PubMed    


  10. MOUCHERAUD C, Kalande P, Chibaka S, Phiri K, et al
    Human papillomavirus vaccination in rural Malawi: Identifying factors associated with vaccine uptake using a community-based household survey.
    Hum Vaccin Immunother. 2025;21:2485651.
    PubMed    
    Abstract available

  11. NASRUDIN N, Sazlina SG, Cheong AT, Lee PY, et al
    Increasing the Uptake of Breast and Cervical Cancer Screening Via the MAwar Application: Stakeholder-Driven Web Application Development Study.
    JMIR Form Res. 2025;9:e65542.
    PubMed    
    Abstract available


  12. RETRACTION: Fibronectin Promotes Cervical Cancer Tumorigenesis Through Activating FAK Signaling Pathway.
    J Cell Biochem. 2025;126:e70022.
    PubMed    
    Abstract available

  13. YAO Y, Tao L, Ma L, Fan Y, et al
    Etiological Factors and Development of a Predictive Model for Urinary Tract Infections in Cervical Cancer Patients Undergoing Intensity-Modulated Radiotherapy.
    Infect Drug Resist. 2025;18:1637-1645.
    PubMed    
    Abstract available

  14. ZHANG L, Xiao M, He XC, Lin YP, et al
    [Analysis of human papillomavirus subtype distribution and cervical lesion characteristics in a cancer hospital in Shenzhen City].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:490-494.
    PubMed    
    Abstract available

  15. LI JH, Liu XX, Tang L, Wang FZ, et al
    [Health economics evaluation of vaccination strategies for different human papillomavirus vaccines for 12-year-old female adolescents in China].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:425-432.
    PubMed    
    Abstract available

  16. SPACEK J, Ndukwe MO, Ubom AEB, Sirak I, et al
    Urologic Fistulas in Czech Women With Gynaecologic Malignancies.
    Cancer Rep (Hoboken). 2025;8:e70134.
    PubMed    
    Abstract available

  17. VOLPI CR, Giuliano AR, Morais E, Felsher M, et al
    Shifting HPV-cancer burden: from cervical cancer to oropharyngeal cancer.
    Infect Agent Cancer. 2025;20:21.
    PubMed    
    Abstract available

  18. DU M, Li Y, Fan X, Gao H, et al
    A rare case of Alveolar Soft-Part Sarcoma in the Uterine cervix.
    Diagn Pathol. 2025;20:33.
    PubMed    
    Abstract available

  19. VEERAVAGU T, Hamdiui N, Stein ML, Crutzen R, et al
    Barriers, facilitators, needs, and preferences in seeking information regarding cervical cancer prevention programs among Turkish, Moroccan, and Syrian immigrant women: a scoping review.
    BMC Public Health. 2025;25:1242.
    PubMed    
    Abstract available

  20. DAI W, Liu Y, Jiang X, Xu R, et al
    The inferred modulation of correlated vaginal microbiota and metabolome by cervical differentially expressed genes across distinct CIN grades.
    BMC Microbiol. 2025;25:189.
    PubMed    
    Abstract available


  21. RETRACTION: Effect of Minimally Invasive Surgery and Laparotomy on Wound Infection and Postoperative and Intraoperative Complications in the Management of Cervical Cancer: A Meta-Analysis.
    Int Wound J. 2025;22:e70467.
    PubMed    
    Abstract available


  22. RETRACTION: Best Practices for Managing Malodorous and Infected Wounds in Advanced Cervical Cancer.
    Int Wound J. 2025;22:e70486.
    PubMed    
    Abstract available

  23. TEWARI KS
    Cervical Cancer. Reply.
    N Engl J Med. 2025;392:1351.
    PubMed    


  24. ROKX C
    Cervical Cancer.
    N Engl J Med. 2025;392:1350-1351.
    PubMed    


  25. HARRIS L
    Cervical Cancer.
    N Engl J Med. 2025;392:1350.
    PubMed    


  26. SUBA EJ
    Cervical Cancer.
    N Engl J Med. 2025;392:1349-1350.
    PubMed    


  27. LEON-MALDONADO L, Cabral A, Pages G, Brown B, et al
    Barriers and facilitators to a combined strategy of HPV vaccination and cervical cancer screening among Mexican women.
    Hum Vaccin Immunother. 2025;21:2483018.
    PubMed    
    Abstract available

  28. POLEBOYINA PK, Pasha A, Heena SK, Poleboyina SM, et al
    Evaluating TGF-beta1 gene expression and promoter polymorphism in cervical cancer progression.
    J Mol Histol. 2025;56:126.
    PubMed    
    Abstract available

  29. TADESE BK, You X, Ndao T, Tota JE, et al
    The Burden of HPV Infections and HPV-Related Diseases Among People With HIV: A Systematic Literature Review.
    J Med Virol. 2025;97:e70274.
    PubMed    
    Abstract available

  30. ISHIKAWA M, Nakayama K, Ishibashi T, Yamashita H, et al
    Outcomes and patterns of recurrence of robot?assisted or laparoscopic radical hysterectomy in early?stage cervical cancer.
    Mol Clin Oncol. 2025;22:43.
    PubMed    
    Abstract available

  31. WU Z, Deng L, Wu W, Zeng B, et al
    A novel skeletal muscle quantitative method and deep learning-based sarcopenia diagnosis for cervical cancer patients treated with radiotherapy.
    Med Phys. 2025 Apr 1. doi: 10.1002/mp.17791.
    PubMed    
    Abstract available

  32. KUE J, Tate JA, Pineiro B, Szalacha LA, et al
    Cultural and Linguistic Adaptation of an Evidence-Based Tailored Navigation Intervention to Increase Cancer Screening Uptake Among Southeast Asian Women.
    Cancer Control. 2025;32:10732748251329867.
    PubMed    
    Abstract available

  33. FENG X, Li J, Li C, Wang J, et al
    SiaQuant Unveils Serum alpha2,3/alpha2,6 Sialylation Heterogeneities and Predicts Neoadjuvant Chemotherapy Response in Locally Advanced Cervical Cancer.
    Anal Chem. 2025 Apr 1. doi: 10.1021/acs.analchem.4c04952.
    PubMed    
    Abstract available

  34. CONDE-RODRIGUEZ I, Perez-Picazo S, Vazquez-Zamora VJ, Reyes-Leyva J, et al
    Serum soluble Tim?3 is elevated in patients with cervical cancer and is higher in advanced clinical stages.
    Biomed Rep. 2025;22:90.
    PubMed    
    Abstract available

  35. HUANG Q, Xu YF, Li HP, Zhang T, et al
    Bioinformatics and experimental approach reveal potential prognostic and immunological roles of key mitochondrial metabolism-related genes in cervical cancer.
    Front Oncol. 2025;15:1522910.
    PubMed    
    Abstract available

  36. BAGHERI Z, Abuei H, Jaafari A, Taki S, et al
    Inhibition of p16 and NF-kappaB Oncogenic Activity in Human Papillomavirus-Infected Cervical Cancer Cells: A New Role for Activating Transcription Factor-3.
    Yale J Biol Med. 2025;98:21-32.
    PubMed    
    Abstract available

  37. WOJEWODA B, Korman M, Kamzol W, Jaglarz-Bialy K, et al
    Knowledge and awareness of cervical cancer and prevention measures among female students in Poland: a cross-sectional, decade apart study.
    J Gynecol Oncol. 2025;36:e23.
    PubMed    
    Abstract available

  38. OLTHOF EP, Wenzel HHB, van Maaren MC, van der Velden J, et al
    Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study.
    J Gynecol Oncol. 2025;36:e16.
    PubMed    
    Abstract available

  39. LIN C, Xiao N, Chen Q, Liao D, et al
    Prognostic implications of tumor volume reduction during radiotherapy in locally advanced cervical cancer: a risk-stratified analysis.
    Radiat Oncol. 2025;20:47.
    PubMed    
    Abstract available

  40. WU T, Wang Y, Cui X, Xue P, et al
    AI-Based Identification Method for Cervical Transformation Zone Within Digital Colposcopy: Development and Multicenter Validation Study.
    JMIR Cancer. 2025;11:e69672.
    PubMed    
    Abstract available

  41. VOJTISEK R, Baxa J, Hosek P, Kovarova P, et al
    Association of long-term treatment outcomes with changes in PET/MRI characteristics and the type of early treatment response during concurrent radiochemotherapy in patients with locally advanced cervical cancer.
    Strahlenther Onkol. 2025 Mar 31. doi: 10.1007/s00066-025-02389.
    PubMed    
    Abstract available

  42. WILLIAMS K, Carmona-Gonzalez M
    Dermatomyositis as a Paraneoplastic Syndrome in Cases of Aggressive Cervical Cancer.
    Cureus. 2025;17:e79838.
    PubMed    
    Abstract available

  43. LIU J, Chen S, Chen J, Liu H, et al
    Effects of perioperative oxycodone as the sole opioid on immunity within a multi-modal analgesia framework in patients undergoing cervical cancer surgery: A randomised controlled trial.
    Indian J Anaesth. 2025;69:191-199.
    PubMed    
    Abstract available

  44. CAO XZ, Zhang YF, Song YW, Yuan L, et al
    DNA methyltransferase 1/miR-342-3p/Forkhead box M1 signaling axis promotes self-renewal in cervical cancer stem-like cells in vitro and nude mice models.
    World J Stem Cells. 2025;17:99472.
    PubMed    
    Abstract available

  45. SHEN C, Zhang J, Zhang G, Luo H, et al
    Research hotspots and trends in the field of immune checkpoint inhibitors (ICIs) for cervical cancer: A bibliometric study from 2014 to 2024.
    Hum Vaccin Immunother. 2025;21:2483031.
    PubMed    
    Abstract available

  46. JIAO YS, Li C, Xiang Y
    [Advances of targeting EZH2 in gynecological malignancies].
    Zhonghua Fu Chan Ke Za Zhi. 2025;60:236-240.
    PubMed    


  47. CHEN YQ, Huang QM, Hong ML, Zhu YQ, et al
    [Value of high-risk HPV viral load in cervical cancer screening and triage: a real world retrospective study based on cervical cancer screening program in Quanzhou, China].
    Zhonghua Fu Chan Ke Za Zhi. 2025;60:193-201.
    PubMed    
    Abstract available

  48. WU GP, Liu DG, Jin ML
    [Advances in cytopathology in China over the past ten years: retrospect and prospect].
    Zhonghua Bing Li Xue Za Zhi. 2025;54:341-347.
    PubMed    
    Abstract available

  49. WANG Y, Xie L, Jin S, Hou Y, et al
    Activation of TRIM37 by ATF6 and degradation of ACSL4: inhibiting ferroptosis and propelling cervical cancer progression.
    Hereditas. 2025;162:47.
    PubMed    
    Abstract available

  50. YOU Q, Li L, Liu L
    An integrated approach of transcriptomics, network pharmacology and molecular docking uncovers the mechanisms of 5,6,7,4'-tetramethoxyflavone in treating cervical cancer.
    Biochem Biophys Res Commun. 2025;760:151611.
    PubMed    
    Abstract available

  51. ALMASABI SHA, Almasoudi HH, Albargy H, Alabbas MMA, et al
    Alternative use of droxidopa for treating cervical cancer: inhibiting transferase, cell cycle signalling, and transport proteins via multitarget docking, DFT, MD simulations, and binding free energy studies.
    Med Oncol. 2025;42:143.
    PubMed    
    Abstract available

  52. EL-ZEIN M, Franco EL
    Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination.
    Expert Rev Mol Diagn. 2025 Apr 4:1-8. doi: 10.1080/14737159.2025.2486653.
    PubMed    
    Abstract available

  53. SILFAROHANA R, Waskita KN, Mar'ah NH, Rohman MS, et al
    Investigating the Potential Synergistic Effects of Turmeric Extract and Black Rice Bran as Cytotoxic Agents Against HeLa Cells.
    Asian Pac J Cancer Prev. 2025;26:1059-1067.
    PubMed    
    Abstract available

  54. RAMAN RR, Meet S, Tiwari HM, Oswal K, et al
    Designing and Implementing a Cancer Screening Program for Underserved Tribal Women in Jharkhand.
    Asian Pac J Cancer Prev. 2025;26:977-984.
    PubMed    
    Abstract available

  55. ALAWADHI E, Albahar S, Tolma E, Longenecker J, et al
    Disparities in the Uptake of Cervical Cancer Screening in Kuwait: A Cross-Sectional Analysis of the Nationwide WHO STEPS Survey.
    Asian Pac J Cancer Prev. 2025;26:861-868.
    PubMed    
    Abstract available

  56. HOMSUP P, Pohthipornthawat N, Ariyasriwatana C, Oranratanaphan S, et al
    Role of Cyclooxygenase-2 (COX-2) Expression as a Prediction of Persistent Cervical Low Grade Squamous Intraepithelial Lesion (LSIL).
    Asian Pac J Cancer Prev. 2025;26:791-797.
    PubMed    
    Abstract available

  57. CHAWLA L, Rajaram S, Sahoo I, Panta S, et al
    Counselling to Screening: Honing an Institutional Cervical Cancer Screening Program.
    Asian Pac J Cancer Prev. 2025;26:785-789.
    PubMed    
    Abstract available

  58. ARAUJO EA, Lima FJL, Cartagenes MDSS, Silva GEB, et al
    Role of SNHGs in Adverse Prognostic Factors in Cervical Cancer: A Systematic Review.
    Asian Pac J Cancer Prev. 2025;26:735-741.
    PubMed    
    Abstract available

  59. KONNO Y, Ohnishi S, Minobe S, Nomura E, et al
    Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting in Patients With Uterine Corpus or Cervical Cancer Treated With Cisplatin-Based Regimen-Placebo-controlled, Double-Blind, Randomized Confirmatory Study (JORTC-KMP03).
    Integr Cancer Ther. 2025;24:15347354251329346.
    PubMed    
    Abstract available

  60. FU K, Yangzom K, Li L, Wu L, et al
    Optimizing the Follow-Up Interval After Successful Cold Knife Conization of CIN3: A 10-Year Retrospective Cohort Study.
    Cancer Med. 2025;14:e70825.
    PubMed    
    Abstract available

  61. AGUS SOMIA IK, Purwanta MLA, Winarti NW, Dwija IBNP, et al
    Prevalence and risk factors of high-risk HPV and cervical abnormalities in HIV-positive women in Bali, Indonesia.
    BMC Infect Dis. 2025;25:432.
    PubMed    
    Abstract available

  62. MORENZ A, Ganguly A, Kessler L, Coronado G, et al
    Asking About Cervical Cancer Screening in National Surveys: Implications for Health Literacy and Research.
    Am J Prev Med. 2025 Mar 26:S0749-3797(25)00103.
    PubMed    
    Abstract available

  63. MACANDER C, Wang H, Galafassi M, Jones GM, et al
    Role of Race, Rurality, and Age in Human Papillomavirus Vaccine Initiation among US Women.
    South Med J. 2025;118:206-210.
    PubMed    
    Abstract available

  64. ACEVEDO-SANCHEZ V, Rodriguez-Hernandez RM, Aguilar-Ruiz SR, Torres-Aguilar H, et al
    Keratinocyte-derived extracellular vesicles induce macrophage polarization toward an M1-like phenotype.
    Biochem Biophys Res Commun. 2025;758:151659.
    PubMed    
    Abstract available

  65. LI Z, Zhang X, Li G, Peng J, et al
    Light scattering imaging modal expansion cytometry for label-free single-cell analysis with deep learning.
    Comput Methods Programs Biomed. 2025;264:108726.
    PubMed    
    Abstract available

  66. UUSKULA A, Tisler A, DeHovitz J, Murenzi G, et al
    Prevention and control of HPV-related cancers in people living with HIV.
    Lancet HIV. 2025;12:e293-e302.
    PubMed    
    Abstract available

  67. JIN C, Luo L, Lin H, Hou J, et al
    HMIL: Hierarchical Multi-Instance Learning for Fine-Grained Whole Slide Image Classification.
    IEEE Trans Med Imaging. 2025;44:1796-1808.
    PubMed    
    Abstract available

  68. LEE M, Andrieu PIC, Nougaret S, Russo L, et al
    Role of MRI in Assessing the Feasibility of Fertility-Sparing Treatments for Early-Stage Endometrial and Cervical Cancers.
    AJR Am J Roentgenol. 2025 Jan 8. doi: 10.2214/AJR.24.32157.
    PubMed    
    Abstract available

  69. ZHANG W, Song Y, Shi H, Lu B, et al
    Further confirmation of a highly prognostic grading scheme based upon tumour budding and cell cluster size in cervical squamous cell carcinoma.
    Histopathology. 2025;86:967-978.
    PubMed    
    Abstract available

  70. KONG L, Xiao X, Wu H, You Y, et al
    Triage performance of DNA methylation for women with high-risk human papillomavirus infection.
    Oncologist. 2025;30:oyae324.
    PubMed    
    Abstract available

  71. YI J, Chen J, Cao X, Pi L, et al
    Development and validation of the competing risk nomogram and risk classification system for predicting cancer-specific mortality in patients with cervical adenosquamous carcinoma treated via radical hysterectomy.
    Biomol Biomed. 2025;25:1099-1110.
    PubMed    
    Abstract available

  72. MIZUNO M, Kamio M, Sakihama M, Yanazume S, et al
    The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.
    Gynecol Obstet Invest. 2025;90:143-152.
    PubMed    
    Abstract available

  73. WANG Y, Tan Y, Yang S, Wei J, et al
    HLTF/SERPINE1 Axis Plays a Crucial Pro-Oncogenic Role in the Progression from Cervical Precancerous Lesions to Cervical Carcinoma in vitro.
    Gynecol Obstet Invest. 2025;90:108-119.
    PubMed    
    Abstract available

  74. WEXLER C, Maloba M, Mabachi N, Maosa N, et al
    Availability and Uptake of Cervical Cancer Screening and Treatment Services at 19 Kenyan Health Facilities: A Brief Report.
    JCO Glob Oncol. 2025;11:e2400255.
    PubMed    
    Abstract available

  75. BENNETT LR, Astari P
    Unpacking cervical cancer stigma in healthcare: lessons learnt from Indonesian patients and health professionals.
    Cult Health Sex. 2025 Apr 11:1-16. doi: 10.1080/13691058.2025.2488036.
    PubMed    
    Abstract available

  76. MATSUMURA N, Mandai M
    PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of amivantamab plus lazertinib for non-small cell lung cancer, durvalumab for small cell lung cancer, tislelizumab for esophageal cancer, tisotuma
    Int J Clin Oncol. 2025 Apr 11. doi: 10.1007/s10147-025-02758.
    PubMed    


  77. KUMAR W, Lohia S, Agrawal A, Yadav V, et al
    A rare case of synchronous cervical squamous cell carcinoma and invasive ductal carcinoma of breast.
    J Cancer Res Ther. 2025;21:281-283.
    PubMed    
    Abstract available

  78. SARAWAGI R, Sharma DN, Kumar R, Subramani V, et al
    Positron emission tomography versus computed tomography -guided intracavitary brachytherapy for locally advanced cervical cancer: A prospective randomized study.
    J Cancer Res Ther. 2025;21:151-155.
    PubMed    
    Abstract available

  79. GOYAL LD, Garg P, Kankaria A, Kaur N, et al
    The current status of cervical cancer awareness and HPV Vaccination among rural women of India: An impediment to the WHO cervical cancer elimination initiative.
    J Cancer Res Ther. 2025;21:57-63.
    PubMed    
    Abstract available

  80. DIAZ-VALLEJO JJ, Lagunes-Baez E, Cordoba-Colorado D, Perez-Vasquez MO, et al
    Determination of Human Papillomavirus Serotypes in Endocervical Samples from Patients with Normal Cytology from a Mexican Population by Polymerase Chain Reaction-restriction Fragment Length Polymorphism.
    Indian J Public Health. 2025;69:115-118.
    PubMed    
    Abstract available

  81. QAMAR J, Maheen M, Mohammad JG
    Insufficient resources for cervical cancer in Pakistan: a significant burden on public health.
    Ann Med Surg (Lond). 2025;87:1114-1116.
    PubMed    


  82. CHOI W, Shim E
    The effects of human papillomavirus vaccination in Japan.
    Hum Vaccin Immunother. 2025;21:2489301.
    PubMed    
    Abstract available

  83. CHEN T, Xu Y, Yang K, Du Y, et al
    Withaferin A combined with ricolinostat: a potent synergistic therapy for cervical cancer through regulating p53 ubiquitination and acetylation.
    Acta Biochim Biophys Sin (Shanghai). 2025 Apr 10. doi: 10.3724/abbs.2025048.
    PubMed    


  84. SEIFU BL, Negussie YM, Asnake AA, Asebe HA, et al
    Wealth-related inequalities of women's cervical cancer screening in 11 Sub-Saharan African countries: evidence from a pooled decomposition analysis.
    Sci Rep. 2025;15:12289.
    PubMed    
    Abstract available

  85. BANO N, Ahmad S, Gupta D, Raza K, et al
    FDA-approved Levophed as an alternative multitargeted therapeutic against cervical cancer transferase, cell cycle, and regulatory proteins.
    Comput Biol Med. 2025;191:110163.
    PubMed    
    Abstract available

  86. JOE TR, Natonie KM, Charley KR, Lee NR, et al
    Increasing HPV and Cervical Cancer Education Among Native American Communities and Healthcare Providers.
    J Cancer Educ. 2025 Apr 10. doi: 10.1007/s13187-025-02619.
    PubMed    
    Abstract available

  87. TAUMBERGER N, Friko I, Der VM, Ellis LB, et al
    Implementing High-Risk Human Papillomavirus Self-Sampling for Cervical Cancer Screening in Ghana: A Study (CarciSCAN) Protocol.
    Cancer Control. 2025;32:10732748251330698.
    PubMed    
    Abstract available

  88. XU Z, Wang M, Gong L, Luo G, et al
    Promising outcomes of the PD-L1 inhibitor Socazolimab in recurrent and metastatic cervical cancer: a case report.
    Front Oncol. 2025;15:1541760.
    PubMed    
    Abstract available

  89. MORALES-CAMPOS DY, Adsul P, Liang Y, Donovan E, et al
    Trusted health system implementation strategies to increase vaccination (TRUE SYNERGI): a stepped-wedge cluster randomized trial to reduce HPV-related cancers.
    BMC Public Health. 2025;25:1331.
    PubMed    
    Abstract available

  90. NESSA A, Azad AK, Uddin SMN, Khan MAH, et al
    Cervical cancer screening data from the case-based national electronic registry in Bangladesh.
    BMC Glob Public Health. 2025;3:34.
    PubMed    
    Abstract available

  91. BAO Q, Tang W, Tang W, Zhu X, et al
    Identification of immune-related cervical cancer prognostic biomarkers and construction of prognostic model based on tumor microenvironment.
    Eur J Med Res. 2025;30:261.
    PubMed    
    Abstract available

  92. VAN DER MERWE M, Myburgh K, Garnis C, Towle R, et al
    Unravelling the role of extracellular vesicles in cervical cancer: Mechanisms of progression, resistance, and emerging therapeutic strategies.
    Gene. 2025 Apr 7:149467. doi: 10.1016/j.gene.2025.149467.
    PubMed    
    Abstract available

  93. ULARNWONG M, Hanamornroongruang S, Ruengkhachorn I, Karnchanabanyong W, et al
    Diagnostic Accuracy of the Siriraj Portable Digital Cervicography Device Versus Standard Colposcopy for Detecting CIN2(+) Lesions.
    J Med Virol. 2025;97:e70339.
    PubMed    
    Abstract available

  94. SUN H, Zhang Y, Wang F, Wang Z, et al
    SORBS3-beta suppresses lymph node metastasis in cervical cancer by promoting the ubiquitination of beta-catenin.
    J Transl Med. 2025;23:406.
    PubMed    
    Abstract available

  95. XING H, Sun R, Ren J, Wei J, et al
    Achieving flexible fairness metrics in federated medical imaging.
    Nat Commun. 2025;16:3342.
    PubMed    
    Abstract available

  96. BIZZARRI N, Schivardi G, Di Martino G, Antonacci A, et al
    Factors associated with bilateral sentinel lymph node mapping failure using indocyanine green in patients with apparent early-stage cervical cancer: An Italian retrospective multi-center study.
    Eur J Surg Oncol. 2025;51:109981.
    PubMed    
    Abstract available

  97. AUTHIER CIPOLLA EC, Tourinan MR, Lamonica CB, Bazzi AR, et al
    [Ectopic ACTH secretion by neuroendocrine carcinoma of the uterine cervix].
    Medicina (B Aires). 2025;85:439-444.
    PubMed    
    Abstract available

  98. NIKOLOULOPOULOS AK
    Vine copula mixed models for meta-analysis of diagnostic accuracy studies without a gold standard.
    Biometrics. 2025;81:ujaf037.
    PubMed    
    Abstract available

  99. BIEDERMAN EB, Stump TE, Monahan PO, Katz ML, et al
    A Randomized Control Trial of Two Interventions Compared to Usual Care for Increasing Cervical Cancer Screening Among Women Living in the Rural Midwest.
    Cancer Epidemiol Biomarkers Prev. 2025 Apr 8. doi: 10.1158/1055-9965.EPI-24-0971
    PubMed    
    Abstract available

  100. ZHAO Z, Peng Y, Yang Y, Li S, et al
    ATP13A2 as a prognostic biomarker and its correlation with immune infiltration in cervical cancer: A retrospective study.
    J Cell Mol Med. 2025;29:e70097.
    PubMed    
    Abstract available

  101. LIU J, Han B, Hu X, Yuan M, et al
    Identification of N6-methyladenosine-associated ferroptosis biomarkers in cervical cancer.
    Hereditas. 2025;162:53.
    PubMed    
    Abstract available

  102. CHABALALA TV, Maimela E, Mashaba RG, Ntimana CB, et al
    Factors that contribute to women's reluctance to undergo cervical cancer screening in clinics of Limpopo Province, South Africa.
    BMC Public Health. 2025;25:1303.
    PubMed    
    Abstract available

  103. HU X, Wang Y, Guo H, Guo Y, et al
    The long noncoding RNA CCDC144NL-AS1: prognosis significance and potential biological functions in cervical carcinoma.
    J Obstet Gynaecol. 2025;45:2463416.
    PubMed    
    Abstract available

  104. DENG E, Gu Z, Wei H, Liu C, et al
    Using Machine Learning to Predict the Prognosis of Cervical Cancer Patients with Lymph Node Metastasis: An Analysis Based on the SEER Database.
    Reprod Sci. 2025 Apr 7. doi: 10.1007/s43032-025-01856.
    PubMed    
    Abstract available

  105. JAWOREK H, Bouska O, Kourilova P, Hajduch M, et al
    High-risk HPV prevalence in the Czech cervical cancer screening population: a comparison of clinician-collected and self-collected sampling.
    Eur J Public Health. 2025 Apr 7:ckaf045. doi: 10.1093.
    PubMed    
    Abstract available

  106. ZHU ZM, Huo FC, Shi C, Li MT, et al
    METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14.
    Int J Biol Macromol. 2025;309.
    PubMed    
    Abstract available

  107. SHAO D, Yu H, Zhu X
    Screening and identification analysis of core markers for leukemia and cervical cancer: Calmodulin 3 as a core target.
    Medicine (Baltimore). 2025;104:e41665.
    PubMed    
    Abstract available

  108. YOUNAS S, Nosheen A, Malik ZI, Hussain N, et al
    Genetic analysis of HPV-16 L1 gene mutations and computational screening of therapeutic inhibitors for cervical cancer treatment.
    Med Oncol. 2025;42:153.
    PubMed    
    Abstract available

  109. SOUZA APO, de Lima LA, Ferreira PAB, Dutra RF, et al
    Advances in Cervical Cancer Diagnostics Based on Immunosensors: Innovative Approaches and Tumor Biomarkers.
    Curr Top Med Chem. 2025 Apr 4. doi: 10.2174/0115680266366335250314081522.
    PubMed    
    Abstract available

  110. WU X, Lin K, Gao C, Ni Y, et al
    miR-627-5p inhibits malignant progression of cervical cancer by targeting ANGPTL4.
    Eur J Histochem. 2025;69.
    PubMed    
    Abstract available

  111. PANG G, Li Y, Shi Q, Tian J, et al
    Omics sciences for cervical cancer precision medicine from the perspective of the tumor immune microenvironment.
    Oncol Res. 2025;33:821-836.
    PubMed    
    Abstract available

  112. PANKAJ S, Rani J, Kumari P, Abhilashi K, et al
    Efficacy of HPV E6/E7 mRNA assay, HPV DNA test and cytology in detection of high grade cervical lesions and invasive cancer at a tertiary care center in India.
    Malawi Med J. 2024;36:120-127.
    PubMed    
    Abstract available

  113. HELLFRITSCH J, Panzer M, Wagner S, Nieschke K, et al
    First Results for the Evaluation of the Cervical Cancer Screening Carried Out in 2021 and 2022 in the Context of the Organized Cancer Screening Program (oKFE): Part 1 - Primary Screening.
    Geburtshilfe Frauenheilkd. 2025;85:417-433.
    PubMed    
    Abstract available

  114. SUN S, Gong X, Liang Y, Sun Y, et al
    Evaluating the Implementation of fan-beam CT-guided online adaptive re-planning in definitive cervical cancer radiotherapy.
    Front Oncol. 2025;15:1509619.
    PubMed    
    Abstract available

  115. GETINET M
    Oncogenic human papillomavirus infection (HPV 16/18) and associated factors among women in East Gojjam Zone, NorthWest Ethiopia 2021.
    Afr Health Sci. 2024;24:9-19.
    PubMed    
    Abstract available

  116. ZHANG Y, Li B, Li J, Zhao J, et al
    NDRG1/2 as a prognostic predictive biomarker of cervical cancer and its correlation with immune infiltration.
    Biomark Med. 2025 Apr 7:1-11. doi: 10.1080/17520363.2025.2483495.
    PubMed    
    Abstract available

  117. BATUR P, Brant A, McCourt C, Schwarz EB, et al
    Society of Family Planning Clinical Recommendation: Contraceptive considerations for individuals with cancer and cancer survivors part 2 - Breast, ovarian, uterine, and cervical cancer.
    Contraception. 2025 Mar 27:110867. doi: 10.1016/j.contraception.2025.110867.
    PubMed    
    Abstract available

  118. CHEN H, Guo K, Bai Z, Lu L, et al
    Advances in the Prevention of Cervical Cancer by Anti-Human Papillomavirus Agents.
    Cancer Med. 2025;14:e70847.
    PubMed    
    Abstract available

  119. REN J, Xie L, Zhu X, Chen X, et al
    Resveratrol interrupts Wnt/beta-catenin signalling in cervical cancer by activating ten-eleven translocation 5-methylcytosine dioxygenase 1.
    Cytokine. 2025;190:156930.
    PubMed    
    Abstract available

  120. MENG X, Song S, Li K, Duan Y, et al
    Application of CT in predicting lymph node metastasis in cervical cancer and construction of a preoperative nomogram.
    Sci Rep. 2025;15:11674.
    PubMed    
    Abstract available

  121. MILLET N, McDermott HJ, Munir F, Edwardson CL, et al
    The feasibility and acceptability of delivering and evaluating a physical activity intervention (ACCEPTANCE) for cervical cancer survivors.
    Pilot Feasibility Stud. 2025;11:42.
    PubMed    
    Abstract available

  122. CHEN L, Liu W, Wang M, Feng Y, et al
    Expression of REV7 has prognostic significance in cervical cancer treated with intensity-modulated radiation therapy.
    Discov Oncol. 2025;16:466.
    PubMed    
    Abstract available

  123. HAITH L, Deaney C, Reesby D, Ellis V, et al
    A Retrospective Observational Study on the Impact of Digital Strategies to Boost Cervical Screening Uptake in Primary Care.
    Cancer Control. 2025;32:10732748251330705.
    PubMed    
    Abstract available

  124. AJAH MI, Dibua MEU, Ajah LO, Chigor NV, et al
    Exploring the role of cervicovaginal microbiota as risk factor for cervical cancer in Sub-Saharan Africa: a systematic review and meta-analysis : By.
    BMC Womens Health. 2025;25:160.
    PubMed    
    Abstract available

  125. HADDISON EC, Engoung DB, Bodo CB, Njie VM, et al
    Overcoming HPV vaccine hesitancy: insights from a successful school-based vaccination campaign in the Saa health district of Cameroon.
    BMC Infect Dis. 2025;25:465.
    PubMed    
    Abstract available

  126. LOPES-NUNES J, Lopes M, Rosado B, Maocha IG, et al
    Vaginal formulation development: A strategy based on aptamer-guided liposome for human papillomavirus-induced lesions.
    Eur J Pharm Biopharm. 2025;210:114693.
    PubMed    
    Abstract available

  127. KANDURI M, Subhash S, Putino R, Mahale S, et al
    IER3: exploring its dual function as an oncogene and tumor suppressor.
    Cancer Gene Ther. 2025;32:450-463.
    PubMed    
    Abstract available

  128. TURPIN A, Tran PL, Encaoua J, Khettab M, et al
    [Cancer of the cervix management in Reunion Island from 2016 to 2020].
    Bull Cancer. 2025;112:396-402.
    PubMed    
    Abstract available

  129. PETRELLI F, Riboldi V, Bruschieri L, Villa A, et al
    First-line treatment of locally advanced cervical carcinoma: An updated systematic review and Bayesian network meta-analysis.
    Cancer Treat Rev. 2025;135:102921.
    PubMed    
    Abstract available

  130. ALQETHAMI A, Alhalal E
    A theory-based educational intervention to increase mothers' intention to vaccinate their daughters against human papillomavirus: A randomised controlled trial.
    Patient Educ Couns. 2025;135:108731.
    PubMed    
    Abstract available

  131. MISZCZYK K, Keczkowska E, Ciebiera M
    Cervical screening during pregnancy - a review of recommendations.
    Ginekol Pol. 2025;96:220-224.
    PubMed    
    Abstract available

  132. DEMA E, Osman R, Soldan K, Field N, et al
    Are there any sociodemographic factors associated with non-uptake of HPV vaccination of girls in high-income countries with school-based vaccination programmes? A systematic review.
    J Epidemiol Community Health. 2025;79:388-396.
    PubMed    
    Abstract available

  133. WANG B, Zhang Q, Wang L, Su H, et al
    ADAMDEC1 promotes cervical squamous cell carcinoma by enhancing the JAK/STAT signaling pathway through modulation of TYMP.
    Naunyn Schmiedebergs Arch Pharmacol. 2025;398:6009-6020.
    PubMed    
    Abstract available

  134. RAMIREZ AT, Mesher D, Baena A, Salgado Y, et al
    Impact of knowledge of HPV positivity on cervical cytology performance in latin america.
    J Natl Cancer Inst. 2024 Nov 12:djae283. doi: 10.1093.
    PubMed    
    Abstract available

  135. BHARTI JN
    Adenoid basal carcinoma cervix - A rare epithelial neoplasm.
    J Cancer Res Ther. 2025;21:226-229.
    PubMed    
    Abstract available

  136. BUKOWSKI A, Hoyo C, Graff M, Vielot NA, et al
    Epigenome-wide differential methylation and differential variability as predictors of high-grade cervical intraepithelial neoplasia (CIN2+).
    Am J Epidemiol. 2025;194:1012-1022.
    PubMed    
    Abstract available

  137. LI S, Tang J, Wang J, Liu X, et al
    Metastasis of Mixed Adenoneuroendocrine Carcinoma of the Uterine Cervix to Thyroid Gland.
    Ear Nose Throat J. 2025;104.
    PubMed    
    Abstract available


  138. RETRACTION: A Meta-Analysis Examining the Impact of Open Surgical Therapy versus Minimally Invasive Surgery on Wound Infection in Females With Cervical Cancer.
    Int Wound J. 2025;22:e70573.
    PubMed    
    Abstract available

  139. ZHOU D, Hou J, Xi J, Li Y, et al
    Cost-benefit analysis of p16(INK4a) immunocytology and liquid-based cytology triage after primary HPV testing for cervical cancer screening in China.
    Infect Agent Cancer. 2025;20:26.
    PubMed    
    Abstract available

  140. TAGHIZADIEH M, Kalantari M, Bakhshali R, Kobravi S, et al
    To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell death.
    Cancer Cell Int. 2025;25:153.
    PubMed    
    Abstract available

  141. TIAN M, Qin F, Sun X, Pang H, et al
    A Hybrid Model-Based Clinicopathological Features and Radiomics Based on Conventional MRI for Predicting Lymph Node Metastasis and DFS in Cervical Cancer.
    J Imaging Inform Med. 2025 Apr 18. doi: 10.1007/s10278-024-01371.
    PubMed    
    Abstract available

  142. ZHANG N, Ling H, Zhang W, Zhang M, et al
    A prediction method for radiation proctitis based on SAM-Med2D model.
    Sci Rep. 2025;15:13426.
    PubMed    
    Abstract available

  143. KORKMAZ ASLAN G, Kilinc Isleyen E, Kartal A
    Associations of eHealth Literacy With Cervical Cancer and Human Papillomavirus Awareness Among Women in Turkiye: A Cross-sectional Study.
    Comput Inform Nurs. 2025 Apr 18. doi: 10.1097/CIN.0000000000001314.
    PubMed    
    Abstract available

  144. EBISCH RMF, Buijssen C, Visser NCM, Siebers AG, et al
    The Risk of Developing Cervical Cancer in the Elderly; Who Benefits From Screening After the Age of 60?
    J Low Genit Tract Dis. 2025 Apr 18. doi: 10.1097/LGT.0000000000000893.
    PubMed    
    Abstract available

  145. XIANG Z, Li Z, Chen X, Fu Y, et al
    Cadonilimab plus chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer: a cost-effectiveness analysis.
    Front Immunol. 2025;16:1562875.
    PubMed    
    Abstract available

  146. LIU RC, Ji YM, Huang J, Du YP, et al
    Charged multivesicular body protein 4C promotes the progression of cervical cancer through the HPV E6/miR?543 axis.
    Oncol Lett. 2025;29:275.
    PubMed    
    Abstract available

  147. JABBARI A, Najafpour Z, Ourang S, Cheraghi M, et al
    Developing and validating key performance indicators for breast, cervical, and colorectal cancer screening programs: a literature review and Delphi survey.
    Front Public Health. 2025;13:1491226.
    PubMed    
    Abstract available

  148. SOLTANIZADEH S, Rosendahl M, Froding LP, Bjorn SF, et al
    After Radical Trachelectomy: Reproductive and Obstetrical Outcomes of Fertility-Sparing Surgery for Cervical Cancer.
    Semin Reprod Med. 2025 Apr 17. doi: 10.1055/s-0045-1808092.
    PubMed    
    Abstract available

  149. CHEN CC, Wang S, Yang JM, Huang CH, et al
    Targeting Signaling Excitability in Cervical and Pancreatic Cancer Cells Through Combined Inhibition of FAK and PI3K.
    Int J Mol Sci. 2025;26:3040.
    PubMed    
    Abstract available

  150. FLORKEMEIER I, Hotze HL, Heyne AL, Hildebrandt J, et al
    Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma.
    Int J Mol Sci. 2025;26:2829.
    PubMed    
    Abstract available

  151. WANG Y, Wang Z, Qu W, Chen F, et al
    Patterns of Co-infection of HPV52 With Other HPV Genotypes and Their Risks of Cervical Precancer and Carcinoma.
    J Med Virol. 2025;97:e70312.
    PubMed    
    Abstract available

  152. REDDY R, Gaiwak V, Goda JS, Teni T, et al
    'Nelfinavir sensitizes a clinically relevant chemo-radioresistant cervical cancer in-vitro model by targeting the AKT-USP15/USP11-HPV16 E6/E7 axis.
    Biochem Biophys Rep. 2025;42:101987.
    PubMed    
    Abstract available

  153. HU M, Ji L, Jin L, Shao M, et al
    Minimally invasive surgery for cervical cancer.
    Oncol Lett. 2025;29:281.
    PubMed    
    Abstract available

  154. BAWUAH A, Wang VQ, Adeleye K, Ameyaw EK, et al
    Mass Media Exposure and Cervical Cancer Screening in Rural Sub-Saharan Africa: A Multi-Country Cross-Sectional Analysis.
    Health Sci Rep. 2025;8:e70663.
    PubMed    
    Abstract available

  155. MOHAMMED E, Kaba M, Taye G, Assefa M, et al
    Reasons for not undergoing cervical cancer screening: perspectives from women and health care providers in Addis Ababa: a qualitative study.
    Front Oncol. 2025;15:1456804.
    PubMed    
    Abstract available

  156. DAI X, Ye X, Ren J, Yang J, et al
    Construction of the preoperative staging prediction model for cervical cancer based on deep learning and MRI: a retrospective study.
    Front Oncol. 2025;15:1557486.
    PubMed    
    Abstract available

  157. HUERTA-PADILLA V, Marrero-Rodriguez D, Taniguchi-Ponciano K, Lopez AE, et al
    Thymopoietin-alpha, -beta, and -gamma Isoforms Increased Expression in Cervical Cancer Cells.
    Can J Infect Dis Med Microbiol. 2025;2025:1668482.
    PubMed    
    Abstract available

  158. KRISHNAMOORTHY S, Vasudevan S, Muruganantham B, Muthusami S, et al
    Epinephrine augments the phosphorylation of EGFR and promote the DNA synthesis and migration of cervical cancer cells.
    3 Biotech. 2025;15:125.
    PubMed    
    Abstract available

  159. LICHTENFELS M, Almeida Lima Nunes R, Mendoza Lopez RV, Alves da Silva C, et al
    Gastrin-releasing peptide receptor: a promising new biomarker to identify cervical precursor lesions and cancer.
    Rev Bras Ginecol Obstet. 2025;47:e-rbgo4.
    PubMed    
    Abstract available

  160. LI H, Zhou D, Wang W, Aimaier R, et al
    Mycosubtilin Induces G1 Phase Block and Autophagy in Cervical Cancer HeLa Cells.
    Probiotics Antimicrob Proteins. 2025 Apr 17. doi: 10.1007/s12602-025-10534.
    PubMed    
    Abstract available

  161. LI C, Ke P
    Regional differences in the disease burden and attributable risk factors of female cancers.
    Sci Rep. 2025;15:13092.
    PubMed    
    Abstract available

  162. ZHU JF, Wang YQ, Yang SM, Wang YL, et al
    Exploring the mechanism of Bruceine D against cervical cancer by network pharmacology and the effect of Bruceine D on the EGFR pathway.
    J Pharm Biomed Anal. 2025;262:116887.
    PubMed    
    Abstract available

  163. WANG X, Du Q, Mai Q, Zou Q, et al
    Targeting FASN enhances cisplatin sensitivity via SLC7A11-mediated ferroptosis in cervical cancer.
    Transl Oncol. 2025;56:102396.
    PubMed    
    Abstract available

  164. ADEGBOYEGA A, Mudd-Martin G, Schoenberg NE, Dignan M, et al
    HPV Self-Sampling Promotion Among African American (AA) and Sub-Saharan African (SAI) Immigrant Women: Adaptation and Usability Testing.
    Int J Environ Res Public Health. 2025;22:317.
    PubMed    
    Abstract available

  165. KARIM MA, Zhang N, Zhao H, Shih YT, et al
    Trends in Medicare payments within the first year of cervical cancer diagnosis, 2010-2019.
    JNCI Cancer Spectr. 2025 Apr 16:pkaf043. doi: 10.1093.
    PubMed    
    Abstract available

  166. WU M, Zhang K, Li Y, Yu B, et al
    Endovaginal coil combined with pelvic array coil magnetic resonance imaging for the preoperative staging of cervical cancer.
    Quant Imaging Med Surg. 2025;15:3189-3197.
    PubMed    
    Abstract available

  167. SHEN L, Wen N, Xia M, Zhang Y, et al
    Erratum: [Corrigendum] Calcium efflux from the endoplasmic reticulum regulates cisplatin?induced apoptosis in human cervical cancer HeLa cells.
    Oncol Lett. 2025;29:274.
    PubMed    
    Abstract available

  168. LIU X, Ren H, Wang A, Liang Z, et al
    SIX1 enhances aerobic glycolysis and progression in cervical cancer through ENO1.
    Hum Cell. 2025;38:88.
    PubMed    
    Abstract available

  169. VALENTIN ME, Abdelal Q, Isern S, Ashby T, et al
    Rapidly progressive pneumonitis days after receiving tisotumab vedotin: a new antibody-drug conjugate.
    BMJ Case Rep. 2025;18:e264150.
    PubMed    
    Abstract available

  170. MA X, Zhang L, Lu J, Xu P, et al
    Development and validation of ADC-based nomogram model for predicting the prognostic factors in preoperative clinical early-stage cervical cancer patients.
    Abdom Radiol (NY). 2025 Apr 15. doi: 10.1007/s00261-025-04944.
    PubMed    
    Abstract available

  171. SASIVIMOLRATTANA T, Liewchalermwong S, Chantratita W, Sensorn I, et al
    Virome capture sequencing for comprehensive HPV genotyping in cervical samples.
    Sci Prog. 2025;108:368504251334515.
    PubMed    
    Abstract available

  172. COOPER S, Schmidt BM, Jama NA, Ryan J, et al
    Factors that influence caregivers' and adolescents' views and practices regarding human papillomavirus (HPV) vaccination for adolescents: a qualitative evidence synthesis.
    Cochrane Database Syst Rev. 2025;4:CD013430.
    PubMed    
    Abstract available

  173. OWUYE AJ, Adefemi AK, Olumodeji AM, Adedeji MO, et al
    Comparative Study of Serum Malondialdehyde in Women with Cervical Cancer and Women with High-Risk Human Papillomavirus Infection at The Lagos State University Teaching Hospital, Lagos.
    West Afr J Med. 2024;41:1120-1128.
    PubMed    
    Abstract available

  174. BLUM AC, Tessema R, Nussbaum L, Hidalgo C, et al
    "The problem is not detection, it is treatment": exploring why women needing pre-cervical cancer care are lost to follow-up at the hospital in Iquitos, Peru.
    BMC Health Serv Res. 2025;25:544.
    PubMed    
    Abstract available

  175. ZHANG S, Wang J, Zhu L
    The overtreatment rate, medical cost and psychological affection of see-and-treat versus three-step approaches in the treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis.
    BMC Womens Health. 2025;25:179.
    PubMed    
    Abstract available

  176. CHAUHAN NK, Singh K, Kumar A, Mishra A, et al
    A hybrid learning network with progressive resizing and PCA for diagnosis of cervical cancer on WSI slides.
    Sci Rep. 2025;15:12801.
    PubMed    
    Abstract available

  177. MATUSIAK K, Bumbuliene Z
    "Polish mothers and cervical cancer prophylaxis. What do they know and what attitude do they have towards HPV vaccination?".
    J Pediatr Adolesc Gynecol. 2025 Apr 12:S1083-3188(25)00239.
    PubMed    
    Abstract available

  178. FAN Y, Liu S, Zhao J, Fu Y, et al
    Intestinal perforation in recurrent cervical cancer following bevacizumab and pembrolizumab therapy: A case report.
    Medicine (Baltimore). 2025;104:e40473.
    PubMed    
    Abstract available

  179. WANG Y, Cui W, Chu DM
    Role of Fascin-1 in cervical cancer metastasis via Wnt/beta-catenin pathway activation.
    Biomol Biomed. 2025 Mar 14. doi: 10.17305/bb.2025.12114.
    PubMed    
    Abstract available

  180. DEAN A, Eldawy N, Mendonca J, Lobaina D, et al
    HPV-Related Knowledge and Impact of Patient-Provider Communication on HPV-Associated Cervical Cancer Awareness and Pap Smear Completion in US Women Aged 21-65 Years.
    Cancers (Basel). 2025;17:1188.
    PubMed    
    Abstract available


  181. Retraction: "Mir-3150B-3P Inhibits the Proliferation and Invasion of Cervical Cancer Cells by Targeting Tnfrsf11A".
    J Investig Med. 2025 Apr 14:10815589251332430. doi: 10.1177/10815589251332430.
    PubMed    


  182. LI N, Peng E, Liu F
    Prediction of lymph node metastasis in cervical cancer patients using AdaBoost machine learning model: analysis of risk factors.
    Am J Cancer Res. 2025;15:1158-1173.
    PubMed    
    Abstract available

  183. HOU Y, Zhang L, Wang H, Wang W, et al
    Development and validation of a risk prediction model for lymph node metastasis in stage IA2-IIA1 cervical cancer based on laboratory parameters.
    Am J Cancer Res. 2025;15:1081-1095.
    PubMed    
    Abstract available

  184. LUO M, Liu Y, Lv Y
    Laparoscopic radical hysterectomy and pelvic lymph node dissection for early cervical cancer effectively improves surgical efficacy.
    Am J Transl Res. 2025;17:2103-2111.
    PubMed    
    Abstract available

  185. ZHANG M, Wang L, Zhang X, Li C, et al
    Cervical Cancer Screening Rates Among Chinese Women - China, 2023-2024.
    China CDC Wkly. 2025;7:321-326.
    PubMed    
    Abstract available

  186. GAO X, Liu G, Zhao Z, Tang Y, et al
    Arsenic enhances cervical cancer cell radiosensitivity by suppressing the DNA damage repair pathway.
    Transl Cancer Res. 2025;14:2078-2094.
    PubMed    
    Abstract available

  187. WANG Y, Wang M, Zhu L
    The impact of bladder volume on dosimetric outcomes in VMAT for cervical cancer patients after surgery.
    J Gynecol Oncol. 2025 Apr 8. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  188. YUAN L, Wen B, Li X, Lei H, et al
    A Chinese prospective cohort research developed and validated a risk prediction model for patients with cervical cancer.
    Cancer Cell Int. 2025;25:142.
    PubMed    
    Abstract available

  189. DE OLIVEIRA CM, Rangeiro R, Osman N, Baker E, et al
    Evaluation of hpv risk groups among women enrolled in the mulher cervical cancer screening study in Mozambique.
    Infect Agent Cancer. 2025;20:24.
    PubMed    
    Abstract available

  190. XUE P, Dang L, Kong LH, Tang HP, et al
    Deep learning enabled liquid-based cytology model for cervical precancer and cancer detection.
    Nat Commun. 2025;16:3506.
    PubMed    
    Abstract available

  191. DOBROSSY L
    [Calvary of cytology-based cervical screening in Hungary].
    Orv Hetil. 2025;166:578-587.
    PubMed    


  192. DOMINIK P, Sonja MK, Robert J, Marcin P, et al
    Effect of vaccination against HPV in the HPV-positive patients not covered by primary prevention on the disappearance of infection.
    Sci Rep. 2025;15:12642.
    PubMed    
    Abstract available

  193. SU L, Xu R, Ren Y, Zhao S, et al
    5-Methylcytosine methylation predicts cervical cancer prognosis, shaping immune cell infiltration.
    J Int Med Res. 2025;53:3000605251328301.
    PubMed    
    Abstract available

  194. YUKSEL GH, Ozaydin AN
    Assessment of Health Beliefs and Motivations for Cervical Cancer Screening.
    Healthcare (Basel). 2025;13:804.
    PubMed    
    Abstract available

  195. AGNILA DRL, Jain R, Diaz MJ, Hudlock TR, et al
    TCR CDR3 chemical complementarity to HPV epitopes is associated with a better outcome for cervical cancer.
    Mamm Genome. 2025 Apr 11. doi: 10.1007/s00335-025-10127.
    PubMed    
    Abstract available

  196. RANASINGHE V, McMillan N
    Novel therapeutic strategies for targeting E6 and E7 oncoproteins in cervical cancer.
    Crit Rev Oncol Hematol. 2025;211:104721.
    PubMed    
    Abstract available

  197. MANJILI DA, Babaei FN, Younesirad T, Ghadir S, et al
    Dysregulated circular RNA and long non-coding RNA-Mediated regulatory competing endogenous RNA networks (ceRNETs) in ovarian and cervical cancers: A non-coding RNA-Mediated mechanism of chemotherapeutic resistance with new emerging clinical capacities
    Arch Biochem Biophys. 2025;768:110389.
    PubMed    
    Abstract available

  198. MALEK M, Moayeri M, Akhavan S, Hasani SS, et al
    Advanced MRI prediction model for anatomical site identification in uterine carcinoma: enhancing diagnostic accuracy.
    Clin Radiol. 2025;84:106852.
    PubMed    
    Abstract available

  199. KEUNG MHT, Mehta N, Lynn E, Pineda E, et al
    Clinical validation of the Roche cobas HPV test on the Roche cobas 6800 system for the purpose of cervical screening and qualification as a second-generation comparator test.
    J Virol Methods. 2025;335:115145.
    PubMed    
    Abstract available

  200. GRAY P, Wang J, Nordqvist Kleppe S, Elfstrom KM, et al
    Population-Based Age-Period-Cohort Analysis of Declining Human Papillomavirus Prevalence.
    J Infect Dis. 2025;231:e638-e649.
    PubMed    
    Abstract available

  201. PORTER VL, Ng M, O'Neill K, MacLennan S, et al
    Rearrangements of viral and human genomes at human papillomavirus integration events and their allele-specific impacts on cancer genome regulation.
    Genome Res. 2025;35:653-670.
    PubMed    
    Abstract available

  202. NAICKER N, Osman F, Naidoo K, Bodley N, et al
    High burden of human papillomavirus and premalignant cervical lesions among women starting HIV treatment in KwaZulu-Natal, South Africa.
    Sex Transm Infect. 2025;101:187-190.
    PubMed    
    Abstract available

  203. HIDAYATULLAH A, Widiastuti D, Putra WE, Rifa'i M, et al
    Virtual Screening, Molecular Docking and Molecular Dynamics Simulation of Bioactive Compounds from Various Indonesian Medicinal Plants as Potential Inhibitors of Human Papillomavirus Type 16 E6 Protein in Cervical Cancer Development.
    Trop Life Sci Res. 2025;36:1-24.
    PubMed    
    Abstract available

  204. JAREEMIT N, Kolaka W, Tiyayon J, Tangjitgamol S, et al
    Risk of CIN2+ in women aged >60 years with abnormal cervical cancer screening: a multicenter retrospective cohort study from the Thai Gynecologic Cancer Society research group.
    J Gynecol Oncol. 2025 Apr 7. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  205. SVENSGAARD SNH, Tranberg M, Andersen B, Petersen LK, et al
    Improving cervical cancer screening participation by introducing HPV vaginal self-sampling to women living with HIV in Denmark- a pilot study.
    BMC Womens Health. 2025;25:202.
    PubMed    
    Abstract available

  206. CSANADI M, Filipi K, Ylli A, Dedja B, et al
    Barriers of organized cervical cancer screening in Albania and Montenegro.
    BMC Public Health. 2025;25:1533.
    PubMed    
    Abstract available

  207. TONG TRS
    Cervical Cancer Screening by Human Papillomavirus Testing of Vulvar Swabs.
    Arch Pathol Lab Med. 2025;149:395.
    PubMed    


  208. ANG JX, Tay SK
    Comparison of Clinical Efficacy of Liquid-Based Cytology and High-Risk Human Papillomavirus Testing With Partial Genotyping in Cervical Screening of Women Below 30 Years Old.
    Cancer Control. 2025;32:10732748251336414.
    PubMed    
    Abstract available

  209. WANG Z, Cheng L, Li G, Cheng H, et al
    Epithelial and macrophage cell interaction in cervical cancer through single-cell RNA-sequencing and spatial analysis.
    Front Immunol. 2025;16:1537785.
    PubMed    
    Abstract available

  210. MADSEN KG, Mosgaard JS, Oshosen M, Swai P, et al
    Barriers and facilitators for implementation of HPV-based cervical cancer screening in Tanzania: a qualitative study among healthcare providers, stakeholders, and Tanzanian women.
    Glob Health Action. 2025;18:2491852.
    PubMed    
    Abstract available

  211. MIAZGA W, Tatara T, Gujski M, Pinkas J, et al
    Global Guidelines and Trends in HPV Vaccination for Cervical Cancer Prevention.
    Med Sci Monit. 2025;31:e947173.
    PubMed    
    Abstract available

  212. AKIS S, Kabaca C, Purut YE, Keles E, et al
    The persistence of HPV type-specific infections in patients following colposcopic examination: An observational study.
    J Obstet Gynaecol Res. 2025;51:e16301.
    PubMed    
    Abstract available

  213. CHAN-ON W, Turinthorn M, Chaiwongkot A, Techawiwattanaboon T, et al
    ANGPTL4 suppresses progression and improves cisplatin sensitivity in cervical cancer.
    Sci Rep. 2025;15:14217.
    PubMed    
    Abstract available

  214. INOMATA Y, Kodama K, Maenohara S, Yagi H, et al
    Retrospective analysis of treatment and prognosis for clear cell carcinoma of the uterine cervix: 15-year experience at a single institution.
    J Obstet Gynaecol Res. 2025;51:e16300.
    PubMed    
    Abstract available

  215. HOMAEI SHANDIZ F, Arastouei S, Hosseini S, Prasad Giri I, et al
    Capecitabine-Enhanced Brachytherapy in Locally Advanced Cervical Cancer: A Phase II Non-Randomized Trial on Safety and Efficacy.
    Cancer Invest. 2025 Apr 23:1-13. doi: 10.1080/07357907.2025.2493238.
    PubMed    
    Abstract available

  216. HAKIM RU, Amin T, Ul Islam SMB
    Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global Epidemiology to Innovative Therapies and Prevention Strategies.
    Cancer Control. 2025;32:10732748251336415.
    PubMed    
    Abstract available

  217. NEDOVIC VUKOVIC M, Barjaktarovic Labovic S, Jaksic M, Vuckovic L, et al
    Cervical cancer mortality trend in Montenegro-1990-2018.
    Eur J Public Health. 2025 Apr 23:ckaf059. doi: 10.1093.
    PubMed    
    Abstract available

  218. AVILA-AGUERO ML, Ospina-Henao S, Brenes-Chacon H, Espinal-Tejada C, et al
    Human Papilloma Virus Vaccination as a Strategy to Eliminate Cervical Cancer: Challenges and Opportunities.
    Vaccines (Basel). 2025;13:297.
    PubMed    
    Abstract available

  219. SANTOS MAPD, Macedo HKS, Bezerra HS, Medeiros AA, et al
    Access to pap smear among black women compared to other racial/ethnic groups: a systematic review with meta-analysis.
    Cien Saude Colet. 2025;30:e01852023.
    PubMed    
    Abstract available

  220. YAMADA Y, Okuhara T, Yokota R, Furukawa E, et al
    Evaluating the understandability and actionability of Japanese human papillomavirus vaccination educational materials on cervical cancer.
    Health Promot Int. 2025;40:daaf034.
    PubMed    
    Abstract available

  221. YADAGIRI U, Shaik R, Kolure R, Fatima T, et al
    Immunotherapeutics in Clinical Trials for Cervical Cancer.
    Cancer Biother Radiopharm. 2025 Apr 22. doi: 10.1089/cbr.2025.0031.
    PubMed    
    Abstract available

  222. WALL JA, Bratches RW, Barton WC, Boitano TK, et al
    Specialty Palliative Care Consultation in Patients with Cervical Cancer: Who and Why?
    J Palliat Med. 2025 Apr 23. doi: 10.1089/jpm.2024.0344.
    PubMed    
    Abstract available

  223. HUANG Q, Su W, Li S, Lin Y, et al
    A bibliometric analysis of artificial intelligence applied to cervical cancer.
    Front Med (Lausanne). 2025;12:1562818.
    PubMed    
    Abstract available

  224. YANG Y, Zhu X, Sun D, Fan J, et al
    Lnc-CNNM3-DT as a protective factor in cervical cancer: regulation of LIAS expression and intracellular copper levels.
    Front Oncol. 2025;15:1571788.
    PubMed    
    Abstract available

  225. CHEN Z, Zhao B
    The role of tumor-associated macrophages in HPV induced cervical cancer.
    Front Immunol. 2025;16:1586806.
    PubMed    
    Abstract available

  226. ZENG J, Yin R
    Rethinking treatment approaches for FIGO stage IVB cervical cancer: personalized strategies and emerging therapies.
    Front Immunol. 2025;16:1567296.
    PubMed    


  227. ZHANG H, Zhou Z, Wang J, Wang S, et al
    Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database.
    Front Immunol. 2025;16:1582050.
    PubMed    
    Abstract available

  228. MORITA C, Fujii Y, Maemura S, Yasuda T, et al
    Late Bladder Rupture and Strangulated Ileus Following Radical Hysterectomy and Radiation Therapy for Cervical Cancer.
    Cureus. 2025;17:e81016.
    PubMed    
    Abstract available


  229. Statement of Retraction: The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK)
    Bioengineered. 2025;16:2496006.
    PubMed    


  230. WANG Y, Ji H, Yang T, Liu Y, et al
    HSP90 regulates dCK stability and inhibits ionizing radiation-induced ferroptosis in cervical cancer cells.
    Cell Death Discov. 2025;11:191.
    PubMed    
    Abstract available

  231. HERZIG VAN WEES S, Bakare AA, Akinsola KO, Salako J, et al
    Building HPV vaccine confidence through codesigned interventions with and for healthcare workers in Nigeria: protocol for a pilot cluster randomised controlled trial.
    BMJ Open. 2025;15:e098308.
    PubMed    
    Abstract available

  232. JIN G, Wang J
    Both complete response and long-term survival after combination therapy with toripalimab in a patient with meta-oligometastases cervical cancer: a case report.
    Front Immunol. 2025;16:1542795.
    PubMed    
    Abstract available

  233. NING L, Li X, Xu Y, Si Y, et al
    Immunogenic cell death genes in single-cell and transcriptome analyses perspectives from a prognostic model of cervical cancer.
    Front Genet. 2025;16:1532523.
    PubMed    
    Abstract available

  234. JOHN-OLABODE SO, Udenze IC, Adejimi AA, Ajie O, et al
    Association between tumour necrosis factor-a polymorphism and cervical cancer in Lagos State, Nigeria.
    Ecancermedicalscience. 2025;19:1845.
    PubMed    
    Abstract available

  235. WANG B, Li L, Wu Z, Qian X, et al
    Long noncoding RNA UCA1 knockdown inhibits cisplatin-resistant cervical cancer tumorigenesis via the miR-195-5p/IKBKB axis.
    Acta Biochim Biophys Sin (Shanghai). 2025 Apr 22. doi: 10.3724/abbs.2025032.
    PubMed    
    Abstract available

  236. HU Y, Cui M
    Meta-analysis of the diagnostic value of SOX1 methylation in different types of cervical cancer.
    World J Surg Oncol. 2025;23:147.
    PubMed    
    Abstract available

  237. SHABANPOUR M, Taherkhani S, Shoja Z, Eftekhari M, et al
    Lineage analysis of human papillomavirus types 33 and 35 based on E6 gene in cervical samples from Tehran, Iran.
    Sci Rep. 2025;15:13736.
    PubMed    
    Abstract available

  238. ZHANG W, Zhao J, Fan X, Chen S, et al
    Targeted demethylation of the EphA7 promoter inhibits tumorigenesis via the SP1/DNMT1 and PI3K/AKT axes and improves the response to multiple therapies in cervical cancer.
    Cell Death Dis. 2025;16:324.
    PubMed    
    Abstract available

  239. LU S, Yang H, Mao P, Chen G, et al
    Vaginal stump rupture due to sexual activity leading to small intestine vaginal hernia and intestinal necrosis in a woman after cervical cancer surgery: A case report.
    Medicine (Baltimore). 2025;104:e41788.
    PubMed    
    Abstract available

  240. YASUDA M, Katoh T, Miyama Y, Honma T, et al
    Histological classification of uterine cervical adenocarcinomas: Its alteration and current status.
    J Obstet Gynaecol Res. 2025;51:e16287.
    PubMed    
    Abstract available

  241. TAGUCHI T, Yokoyama M, Fujita T, Tanba S, et al
    Utility of circulating human papillomavirus DNA as a biomarker for detection and prognosis of cervical cancer in Japanese patients.
    Int J Clin Oncol. 2025 Apr 21. doi: 10.1007/s10147-025-02762.
    PubMed    
    Abstract available

  242. KRISHNA A, N V, Shada F, Ms P, et al
    Pre-treatment blood parameters as an economical predictive marker for predicting treatment response in locally advanced cervical cancer.
    F1000Res. 2025;14:118.
    PubMed    
    Abstract available

  243. WANG F, Hengudomsub P, Chantamit-O-Pas C
    Factors related to stigma among patients with cervical cancer having chemotherapy after surgery in China: A cross-sectional study.
    Belitung Nurs J. 2025;11:194-204.
    PubMed    
    Abstract available

  244. HOSSEINI SF, Jalali Nadoushan M, Fekrirad Z, Rasooli I, et al
    Omp34-Mediated Acinetobacter baumannii Invasion of Human Cervical Carcinoma Epithelial, HeLa Cells, and the Influence of Anti-Omp34 Antibodies.
    Anal Cell Pathol (Amst). 2025;2025:1931119.
    PubMed    
    Abstract available

  245. LIU ZP, Liu SH, Zhao H, Ruan FY, et al
    Pathologically Complete Response to Camrelizumab and Apatinib in Advanced Cervical Cancer with PTEN, PIK3CA, MTOR, and ARID1A Mutations: A Case Report.
    Case Rep Oncol. 2025;18:480-492.
    PubMed    
    Abstract available

  246. ZHAO X, Hou S, Hao R, Zang Y, et al
    Prognostic significance of circulating tumor DNA detection and quantification in cervical cancer: a systematic review and meta-analysis.
    Front Oncol. 2025;15:1566750.
    PubMed    
    Abstract available

  247. LIAO J, Moshoeshoe R, Holmes MD, Subramanian SV, et al
    Effect of girls' education on cancer awareness and screening in a natural experiment in Lesotho.
    Nat Commun. 2025;16:3737.
    PubMed    
    Abstract available

  248. ALHUDHUD M, Maqsood S, Hussein ME, Shaheen R, et al
    Cervical cancer screening: a comparative study of TruScreen vs. Pap Smear.
    BMC Womens Health. 2025;25:198.
    PubMed    
    Abstract available

  249. LU M, Luo X, Bu Q, Li P, et al
    Association between low-grade cervical cytology and histological cervical intraepithelial neoplasia concurrent vaginal intraepithelial neoplasia among outpatient colposcopy: A retrospective study.
    J Obstet Gynaecol Res. 2025;51:e16289.
    PubMed    
    Abstract available

  250. QU T, Zeng G, Yang J, Tang K, et al
    Sentinel lymph node biopsy mapped with carbon nanoparticle suspensions in patients with cervical cancer: a systematic review and meta-analysis.
    Jpn J Clin Oncol. 2025 Apr 20:hyaf063. doi: 10.1093.
    PubMed    
    Abstract available

  251. LIAO J, Deng S, Shi B, Wang M, et al
    HPV16 E7 inhibits HBD2 expression by down-regulation of ASK1-p38 MAPK pathway in cervical cancer.
    Virol J. 2025;22:109.
    PubMed    
    Abstract available

  252. MADHUKARAN S, Fomina YY, Mahendroo M
    Cervical function in pregnancy and disease: new insights from single-cell analysis.
    Am J Obstet Gynecol. 2025;232.
    PubMed    
    Abstract available

  253. HUNSBERGER KS, Kapp DS, Chan JK, Irwin CM, et al
    Suicide rates of cervical cancer patients in the United States - Who is most at risk? A retrospective study of 69,493 patients.
    J Cancer Policy. 2025;44:100586.
    PubMed    
    Abstract available

  254. CHEN B, Gao J, Sun H, Chen Z, et al
    Surface-Enhanced Raman Scattering (SERS) combined with machine learning enables accurate diagnosis of cervical cancer: from molecule to cell to tissue level.
    Crit Rev Oncol Hematol. 2025 Apr 17:104736.
    PubMed    
    Abstract available

  255. YIN Q, Sun B, Qi X, Wu C, et al
    Anticancer activity of Momordica charantia-derived extracellular vesicle-like particle against cervical cancer.
    Tissue Cell. 2025;95:102897.
    PubMed    
    Abstract available

  256. SUN H, Liang Z, Zang Y, Liu S, et al
    Transcriptome analysis reveals possible antitumor mechanism of intracellular polysaccharide from Phaeodactylum tricornutum on cervical cancer HeLa cells.
    Chem Biodivers. 2025 Apr 19:e202402779. doi: 10.1002/cbdv.202402779.
    PubMed    
    Abstract available

  257. BAUTISTA-GONZALEZ E, Quintero Leyra A, Munoz Rocha TV, Reyes-Garcia HT, et al
    Assessing disparities in cancer resources distribution in Mexico.
    BMC Health Serv Res. 2025;25:564.
    PubMed    
    Abstract available

  258. EINARSON TA, Musana E, Balonde J, Lorentzen KB, et al
    Human papillomavirus awareness, vaccination rate, and sociodemographic covariates of vaccination status in a low-income country: A cross-sectional study in the rural Busoga region of Uganda.
    Vaccine. 2025;53:127089.
    PubMed    
    Abstract available

  259. DAVIDSON N, Fisher J
    "If I know about it of course I would give my son and daughter", barriers to and enablers of accessing human papillomavirus vaccination among women from refugee and asylum-seeking backgrounds resettling in Melbourne, Australia - A qualitative study.
    Vaccine. 2025;53:127064.
    PubMed    
    Abstract available

  260. TIMOSHENKO O, Kugaevskaya E, Gureeva T, Morozevich G, et al
    Isoxazolyl steroid blocks the Shh signaling pathway and the expression of MMP-2 and MMP-9 in cervical carcinoma cell lines.
    Steroids. 2025;217:109599.
    PubMed    
    Abstract available

  261. PENG Q, Fan P, Wang X, Tao F, et al
    The impact of plan complexity on dose delivery deviations resulting from multileaf collimator positioning errors in volumetric modulated arc therapy.
    Br J Radiol. 2025;98:785-792.
    PubMed    
    Abstract available

  262. HARINATH L, Elishaev E, Ye Y, Matsko J, et al
    Diagnostic performance of the hologic genius digital diagnostics system for low-grade squamous intraepithelial lesion (LSIL) ThinPrep papanicolaou tests.
    J Am Soc Cytopathol. 2025;14:199-207.
    PubMed    
    Abstract available

  263. SMALL C, Ortiz S, Bedi M, Joyner M, et al
    How do you do it?: Gynecologic brachytherapy best practices at high volume institutions within the United States and Canada.
    Brachytherapy. 2025;24:365-370.
    PubMed    
    Abstract available

  264. TANG X, Yang B, Bian W, Li K, et al
    A Multicenter Study on the Relationship of Tumor Lesion Location with Bilateral Parametrial Involvement and Pelvic Lymph Node Metastasis in Cervical Squamous Cell Carcinoma.
    Ann Surg Oncol. 2025;32:3449-3457.
    PubMed    
    Abstract available

  265. LONG X, Ma X, Xiao W, Lv J, et al
    Clinicopathologic and Genomic Features of Invasive Stratified Mucin-producing Carcinoma of the Uterine Cervix Coexisting With High-grade Squamous Intraepithelial Lesion.
    Int J Gynecol Pathol. 2025;44:268-273.
    PubMed    
    Abstract available

  266. NGUYEN DT, Waring D, Wan KM, Loo C, et al
    Superficial and Invasive Spread of High-grade Squamous Intraepithelial Lesion and Squamous Cell Carcinoma: A Case Report.
    Int J Gynecol Pathol. 2025;44:265-267.
    PubMed    
    Abstract available

  267. BEN-MUSSA A, Shah R, Rajendran S, McCluggage WG, et al
    A Population-based Study Investigating the Incidence of Human Papillomavirus-Associated and Human Papillomavirus-Independent Cervical Adenocarcinomas.
    Int J Gynecol Pathol. 2025;44:249-254.
    PubMed    
    Abstract available

  268. VON KNEBEL DOEBERITZ M
    p16INK4a/Ki67 Dual-Staining Immunocytochemistry to Refer Women Infected by High-Risk Human Papillomavirus for Colposcopy.
    Acta Cytol. 2025;69:16-25.
    PubMed    
    Abstract available

  269. SUNDQVIST A, Hellsten C, Strander B, Lindh M, et al
    Self-collected vaginal HPV samples for long-term non-attendees in the Swedish organized cervical cancer screening program.
    Acta Obstet Gynecol Scand. 2025 Apr 7. doi: 10.1111/aogs.15112.
    PubMed    
    Abstract available

  270. KAMIJO K, Miyamoto T, Oshima S, Asaka S, et al
    Extensive Pathologic Invasion and Prognostic Implication of Gastric-Type Cervical Adenocarcinoma: A Comparative Analysis With Human Papillomavirus-Associated Adenocarcinoma.
    Am J Surg Pathol. 2025;49:471-480.
    PubMed    
    Abstract available

  271. WILLIAMS GA 2ND, Wu AA, Eugene HC, Tsai YC, et al
    Clinicopathologic Features and Viral Status of Low-risk HPV6 and HPV11-Associated Squamous Cell Carcinoma of the Uterine Cervix and Vulva.
    Am J Surg Pathol. 2025 Jan 31. doi: 10.1097/PAS.0000000000002367.
    PubMed    
    Abstract available

  272. GERHARD R, Colmenarez CR, Selle C, Hammer GP, et al
    Digital Cytology Combined With Artificial Intelligence Compared to Conventional Microscopy for Anal Cytology: A Preliminary Study.
    Cytopathology. 2025;36:250-258.
    PubMed    
    Abstract available

  273. ASSUNCAO LD, Discacciati MG, da Silva AG, Yoshida A, et al
    Clinical Performance of a Liquid Preservation Medium for Cervicovaginal Samples in DNA-HPV Testing and Liquid-Based Cytology for Cervical Cancer Screening.
    Cytopathology. 2025 Apr 23. doi: 10.1111/cyt.13495.
    PubMed    
    Abstract available

  274. LIN YS, Athanasatos P
    Evaluating the Cytomorphologic Features of Cervical Adenosquamous Carcinoma.
    Diagn Cytopathol. 2025;53:256-261.
    PubMed    
    Abstract available

  275. ONAL C, Elmali A, Demirhan B, Guler OC, et al
    Letter comments on: "Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial".
    Eur J Cancer. 2025 Apr 22:115448. doi: 10.1016/j.ejca.2025.115448.
    PubMed    


  276. AYNAUD O, Huynh B, Bergeron C
    Should men whose female partners have cervical high grade intraepithelial lesion (HSIL) be screened?
    Eur J Obstet Gynecol Reprod Biol. 2025;308:257-260.
    PubMed    
    Abstract available

  277. HAUGE E, Gustafson LW, Tranberg M, Bor P, et al
    Risk of cervical stenosis after cervical excision in postmenopausal patients.
    Eur J Obstet Gynecol Reprod Biol. 2025;308:208-213.
    PubMed    
    Abstract available

  278. YUE X, Duan Y, Guo D, Wang Y, et al
    Diagnostic accuracy of available methylation assays in advanced cervical intraepithelial neoplasia from high-risk HPV-positive women: A systematic review and network meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2025;308:54-65.
    PubMed    
    Abstract available

  279. WOLF B, Trantaki DS, Horn LC, Aktas B, et al
    Preoperative conization in cervical cancer patients undergoing open abdominal radical hysterectomy: Results from a propensity-score matched study.
    Gynecol Oncol. 2025;196:69-77.
    PubMed    
    Abstract available

  280. LORUSSO D, Oaknin A, Borges GS, Damian F, et al
    Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial.
    Gynecol Oncol. 2025;196:28-35.
    PubMed    
    Abstract available

  281. VELASQUEZ J, Mohammed-Norgan M, Scheiber A, Chalif J, et al
    Cross-language insights: Comparing Spanish and English-language cervical cancer content on TikTok.
    Gynecol Oncol. 2025;194:131-136.
    PubMed    
    Abstract available

  282. BORCINOVA M, Kohler C, Nemejcova K, Zapardiel I, et al
    Preoperative tumour size assessment in patients with early-stage cervical cancer: Final results of the SENTIX study.
    Gynecol Oncol. 2025;196:160-167.
    PubMed    
    Abstract available

  283. FRIEDMAN EL, Guo XM, Furey KB, Lee AJ, et al
    Temporal trends of sentinel lymph node biopsy without lymphadenectomy at cervical cancer surgery.
    Gynecol Oncol. 2025;196:182-191.
    PubMed    
    Abstract available

  284. LEATH CA 3RD, Deng W, Mell LK, Richardson DL, et al
    Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.
    Gynecol Oncol. 2025;195:122-133.
    PubMed    
    Abstract available

  285. ZHANG Z, Shi H, Shao Y, Lu B, et al
    Clinicopathologic and molecular characterization of primitive neuroectodermal tumors (PNET) in the female genital tract: a retrospective study of 8 cases.
    Hum Pathol. 2025;157:105769.
    PubMed    
    Abstract available

  286. HARPER DM, Paczos T, Ridder R, Huh WK, et al
    p16/ki-67 dual stain triage of individuals positive for HPV to detect cervical precancerous lesions.
    Int J Cancer. 2025 Feb 4. doi: 10.1002/ijc.35353.
    PubMed    
    Abstract available

  287. FUSEINI NM, El Joueidi S, Montgomery T, Lemrabott E, et al
    Cervical precancer screening and treatment in Nouakchott, Mauritania: Pilot program to inform development of Mauritania's national cervical cancer prevention program.
    Int J Gynaecol Obstet. 2025 Apr 11. doi: 10.1002/ijgo.70145.
    PubMed    


  288. SHANG X, Kong L, You Y, Wu H, et al
    Cytologic DNA methylation for managing minimally abnormal cervical cancer screening results.
    Int J Gynaecol Obstet. 2025 Apr 16. doi: 10.1002/ijgo.70167.
    PubMed    
    Abstract available

  289. BIZZARRI N, Kyrgiou M, De Vincenzo R, Zapardiel I, et al
    Prophylactic HPV vaccination in HPV-related gynecologic cancers: European Society of Gynecological Oncology (ESGO) prevention committee opinion.
    Int J Gynaecol Obstet. 2024 Dec 30. doi: 10.1002/ijgo.16120.
    PubMed    
    Abstract available

  290. MUNGO C, Omoto J, Ogollah C, Owaya A, et al
    Safety and adherence to self-administered intravaginal 5-fluorouracil cream following cervical intraepithelial neoplasia (CIN) 2/3 treatment among HIV-positive women in Kenya: A phase 1 clinical trial.
    Int J Gynaecol Obstet. 2024 Dec 26. doi: 10.1002/ijgo.16093.
    PubMed    
    Abstract available

  291. MORICE P, Gouy S, Plante M, Abu-Rustum N, et al
    Neoadjuvant chemotherapy in stage IB2 to IB3 cervical cancer: because we can or because we must?
    Int J Gynecol Cancer. 2025 Mar 14:101770. doi: 10.1016/j.ijgc.2025.101770.
    PubMed    


  292. LIMA WAL, Gouveia MC, Oliveira LCM, Scaranti M, et al
    Revolutionizing first-line cervical cancer treatment: bevacizumab, immunotherapy, and emerging insights.
    Int J Gynecol Cancer. 2025 Jan 28:101661. doi: 10.1016/j.ijgc.2025.101661.
    PubMed    


  293. LIAO J, Xu T, Zhou J, Xiao N, et al
    The impact of chemotherapy on survival in patients aged >/=65 years with locoregionally cervical cancer who undergo radiotherapy: a Surveillance, Epidemiology, and End Results database analysis.
    Int J Gynecol Cancer. 2025 Mar 3:101747. doi: 10.1016/j.ijgc.2025.101747.
    PubMed    
    Abstract available

  294. LEITAO MM JR, Bixel KL, Chase DM, Quick A, et al
    ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer.
    Int J Gynecol Cancer. 2025 Feb 28:101760. doi: 10.1016/j.ijgc.2025.101760.
    PubMed    
    Abstract available

  295. GAO H, Wu H, Zhang Y, Li X, et al
    Long-term survival in patients with para-aortic metastatic cervical cancer receiving simultaneous integrated boost chemoradiation to positive lymph nodes: a single-center experience.
    Int J Gynecol Cancer. 2024;34:1536-1546.
    PubMed    
    Abstract available

  296. GUO XM, Roman LD, Matsuo K
    Considerations for route of hysterectomy in low-risk cervical cancer.
    Int J Gynecol Cancer. 2024;34:1481.
    PubMed    


  297. MATSUO K, Shimada M, Matsuzaki S, Machida H, et al
    Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer.
    Int J Gynecol Cancer. 2024;34:1349-1358.
    PubMed    
    Abstract available

  298. BIZZARRI N, Abu-Rustum NR, Plante M, Ramirez PT, et al
    Assessing minimally invasive simple hysterectomy in low risk cervical cancer: set up for the LASH trial.
    Int J Gynecol Cancer. 2024;34:1805-1808.
    PubMed    
    Abstract available

  299. CHEN M, Han L, Wang Y, Chen Y, et al
    Association between Silva pattern-based classification and endocervical adenocarcinoma: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2024;34:1704-1710.
    PubMed    
    Abstract available

  300. CHAMBULE S, Rangeiro R, Batman S, Lathrop E, et al
    Scaling cervical cancer screening in Mozambique: analysis of loop electrosurgical excision procedure (LEEP) specimens.
    Int J Gynecol Cancer. 2024;34:1698-1703.
    PubMed    
    Abstract available

  301. MEKURIA SF, Biazin H, Abebe T, Borgfeldt C, et al
    Comparing visual inspection with acetic acid, with and without Lugol's Iodine for triage of HPV self-sample positive women in Ethiopia: a randomized controlled trial.
    Int J Gynecol Cancer. 2024;34:1691-1697.
    PubMed    
    Abstract available

  302. LINDEGAARD JC, Petric P, Tan LT, Hoskin P, et al
    Are we making progress in curing advanced cervical cancer-again?
    Int J Gynecol Cancer. 2024;34:1940-1945.
    PubMed    
    Abstract available

  303. GOLIA D'AUGE T, Caruso G, Laudani ME, Nazzaro L, et al
    Para-aortic lymph node recurrence in surgically treated early-stage cervical cancer without para-aortic lymph node surgical staging.
    Int J Gynecol Cancer. 2024;34:1867-1873.
    PubMed    
    Abstract available

  304. PAN TL, Pareja R, Chiva L, Rodriguez J, et al
    Accuracy of pre-operative tumor size assessment compared to final pathology and frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical cancer.
    Int J Gynecol Cancer. 2024;34:1861-1866.
    PubMed    
    Abstract available

  305. SALANI R, McCormack M, Kim YM, Ghamande S, et al
    A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04).
    Int J Gynecol Cancer. 2024;34:1140-1148.
    PubMed    
    Abstract available

  306. TESFAI FM, Yongue G, Chandrasekaran D, Francis N, et al
    Methods of surgical quality assurance in cervical and endometrial cancer trials: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2025;35:100018.
    PubMed    
    Abstract available

  307. PAVONE M, Baby B, Carles E, Innocenzi C, et al
    Critical view of safety assessment in sentinel node dissection for endometrial and cervical cancer: artificial intelligence to enhance surgical safety and lymph node detection (LYSE study).
    Int J Gynecol Cancer. 2025;35:101789.
    PubMed    
    Abstract available

  308. WANG G, Chen Y, Wang Z, Zeng Z, et al
    A prospective single-arm study of daily online adaptive radiotherapy for cervical cancer with reduced PTV margin: acute toxicity and dosimetric outcomes.
    Int J Radiat Oncol Biol Phys. 2025 Apr 1:S0360-3016(25)00309.
    PubMed    
    Abstract available

  309. SUN DS, Gong X, Cheng S, Cao R, et al
    Fully Automated Online Adaptive Radiotherapy Decision Making for Cervical Cancer Using Artificial Intelligence.
    Int J Radiat Oncol Biol Phys. 2025 Apr 17:S0360-3016(25)00379.
    PubMed    
    Abstract available

  310. WANG V, Lykken JM, Tiro JA, Perkins RB, et al
    Guideline-Concordant Surveillance After Treatment for High-Grade Cervical Dysplasia.
    Obstet Gynecol. 2025;145:461-468.
    PubMed    
    Abstract available

  311. TAGHADOS Z, Azimifar Z, Monsefi M, Jahromi MA, et al
    CausalCervixNet: convolutional neural networks with causal insight (CICNN) in cervical cancer cell classification-leveraging deep learning models for enhanced diagnostic accuracy.
    BMC Cancer. 2025;25:607.
    PubMed    
    Abstract available

  312. WEN K, Wang L, Su H, Yu L, et al
    Development of a m6A- and ferroptosis-related LncRNA signature for forecasting prognosis and treatment response in cervical cancer.
    BMC Cancer. 2025;25:580.
    PubMed    
    Abstract available

  313. GE Y, Wu F, Zhang Y, Wang X, et al
    Prevalence of HPV infection and cervical lesions among women with pelvic organ prolapse and implications for preoperative evaluation.
    BMC Cancer. 2025;25:624.
    PubMed    
    Abstract available

  314. ZHANG C, Chen L
    6-Methoxyflavone inhibits glycolytic energy metabolism in HeLa cells.
    BMC Cancer. 2025;25:719.
    PubMed    
    Abstract available

  315. XAVIER SP, Galvao ND, das Neves MAB, da Silva KM, et al
    Nomogram model for predicting the long-term prognosis of cervical cancer patients: a population-based study in Mato Grosso, Brazil.
    BMC Cancer. 2025;25:684.
    PubMed    
    Abstract available

  316. KHIARI H, Abdelfatteh YB, Mahjoub N, Mekni K, et al
    Trends and projections in cervical cancer incidence in northern Tunisia (1994-2040).
    BMC Cancer. 2025;25:739.
    PubMed    
    Abstract available

  317. BURKE-GARCIA A, Cutroneo E, Afanaseva D, Madden K, et al
    Findings from a qualitative analysis: Social media influencers of color as trusted messengers of HPV vaccination messages.
    PLoS One. 2025;20:e0319160.
    PubMed    
    Abstract available

  318. MAFI S, Theuillon F, Meyer S, Woillard JB, et al
    Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples.
    PLoS One. 2025;20:e0320978.
    PubMed    
    Abstract available

  319. AVILA E, Hernandez-Monterde LD, Cedro-Tanda A, Lizardi-Aguilera TM, et al
    Transcriptomic profile induced by calcitriol in CaSki human cervical cancer cell line.
    PLoS One. 2025;20:e0319812.
    PubMed    
    Abstract available

  320. WANG G, Jia C, Wang D, Liang L, et al
    Scutellaria Barbata inhibits epithelial-mesenchymal transformation through PI3K/AKT and MDM2 thus inhibiting the proliferation, migration and promoting apoptosis of Cervical Cancer cells.
    PLoS One. 2025;20:e0321556.
    PubMed    
    Abstract available

  321. ABATE A, Munshea A, Nibret E, Bezabih B, et al
    Evaluation of Onco E6 point of care rapid diagnostic test for human papilloma virus in Bahir Dar, Amhara Regional State, Ethiopia.
    PLoS One. 2025;20:e0321076.
    PubMed    
    Abstract available

  322. BAASLAND I, Bjorge T, Engesaeter B, Trope A, et al
    Cervical intraepithelial neoplasia grade 1 and long-term risk of progression and treatment.
    PLoS One. 2025;20:e0320739.
    PubMed    
    Abstract available

  323. MELAKU A, Abebe SN, Haile S
    Utilization of screening services on cervical cancer and associated factors among female health workers in Addis Ababa, Ethiopia.
    PLoS One. 2025;20:e0321662.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;